The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews
DOI 10.1124/pr.55.3.3

Cites (435)

Items 201–400 of 436

  1. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
    Jerry M Kokoshka, Roxanne A. Vaughan, Glen R. Hanson, Annette E. Fleckenstein · 1998 · European Journal of Pharmacology
  2. Pharmacological Studies of the Acute Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity, Role of 5-HT1B/1D and 5-HT2 Receptors
    Michael G. Bankson · 2002 · Neuropsychopharmacology
  3. Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin
    Matthias E. Liechti · 2001 · Neuropsychopharmacology
  4. Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat
    Hugh M. Marston, M Reid, Jane A. Lawrence, Henry J. Olverman, Steven P. Butcher · 1999 · Psychopharmacology
  5. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (‘ecstasy’) on the 5-HT and dopamine concentrations in mouse brain
    Esther O’Shea, B. Moreno Esteban, Jorge Camarero, A.R. Green, M. Isabel Colado · 2001 · Neuropharmacology
  6. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice
    Stephanie C. Dulawa, Mark A. Geyer · 2000 · Neuropharmacology
  7. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    William Slikker, R.Robert Holson, Ali Sf, Kolta Mg, Merle G. Paule, Andrew C. Scallet, D E McMillan, Bailey, Jau‐Shyong Hong, Scalzo Fm · 1989 · PubMed
  8. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
    Vollenweider, F. X., Remensberger, S., Hell, D., Geyer, M. A. · 1999 · Psychopharmacology
  9. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam
    Annis O. Mechan, Paula M. Moran, Martin J. Elliott, Andrew M. Young, M. H. Joseph, Richard A. Green · 2001 · Psychopharmacology
  10. The distribution of 3,4-methylenedioxymethamphetamine “Ecstasy”-induced c-fos expression in rat brain
    Chris P Stephenson, Glenn E. Hunt, Ann N. Topple, Iain S. McGregor · 1999 · Neuroscience
  11. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine
    Diane Bemis Miller, James Patrick O'Callaghan · 1995 · Molecular Neurobiology
  12. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence
    Richard Ian Dafters, Frances Duffy, Patrick J. O'Donnell, Caroline Bouquet · 1999 · Psychopharmacology
  13. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    S. Yamawaki, Hong‐Shiee Lai, A. Horita · 1983 · Journal of Pharmacology and Experimental Therapeutics
  14. CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA)
    Jean Lud Cadet, Bruce Ladenheim, Ira Baum, Elaine J. Carlson, Charles J. Epstein · 1994 · Brain Research
  15. 2,5-bis-(Glutathion-S-yl)-α-methyldopamine, a putative metabolite of (±)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations
    Richard Timothy Miller, Serrine S. Lau, Terrence J. Monks · 1997 · European Journal of Pharmacology
  16. Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT 1B receptor
    Kimberly A. Scearce-Levie, Sandya S. Viswanathan, René Hen · 1999 · Psychopharmacology
  17. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.
    Robert Lew, Karen E. Sabol, C Chou, Georgetta L. Vosmer, Jerry B. Richards, Lewis S. Seiden · 1996 · Journal of Pharmacology and Experimental Therapeutics
  18. Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users
    Lawrence H. Price · 1989 · Archives of General Psychiatry
  19. α-Lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity
    Norberto Aguirre, Meritxell Barrionuevo, María Javier Ramírez, Joaquı́n Del Rı́o, Berta Lasheras · 1999 · Neuroreport
  20. A fast model independent method for automatic correction of intensity nonuniformity in MRI data
    Elizabeth A. Vokurka, N. A. Thacker, Alan Jackson · 1999 · Journal of Magnetic Resonance Imaging
  21. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field
    Annis O. Mechan, Paula M. Moran, Martin J. Elliott, Andrew M. Young, M. H. Joseph, Richard A. Green · 2001 · Psychopharmacology
  22. Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs
    Christopher J. Schmidt · 1987 · European Journal of Pharmacology
  23. Caveat Emptor Editors Beware
    U. McCann · 2001 · Neuropsychopharmacology
  24. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons
    Christopher J. Schmidt, Vicki L. Taylor · 1988 · European Journal of Pharmacology
  25. Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy)
    Subramaniam Jayanthi, Bruce Ladenheim, Anne Milasincic Andrews, Jean Lud Cadet · 1999 · Neuroscience
  26. Long term psychiatric and cognitive effects of MDMA use
    Philip K. McGuire · 2000 · Toxicology Letters
  27. A BEHAVIOURAL AND BIOCHEMICAL STUDY IN RATS OF 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE‐ACTIVITY REQUIREMENTS FOR THE AGONISTS
    A.R. GREEN, Jessicka Hall, Anthony R. Rees · 1981 · British Journal of Pharmacology
  28. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates
    George A. Ricaurte, Louis E. DeLanney, Sandra G. Wiener, Ian Irwin, J. William Langston · 1988 · Brain Research
  29. The Anxiogenic-Like and Anxiolytic-Like Effects of MDMA on Mice in the Elevated Plus-Maze A Comparison With Amphetamine
    H Lin · 1999 · Pharmacology Biochemistry and Behavior
  30. Altered neuroendocrine and behavioral responses to m -chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users
    U. McCann, Melissa Mertl, Dennis L. Murphy, Victoria Eligulashvili, George A. Ricaurte · 1999 · Psychopharmacology
  31. Some behavioural and neurochemical aspects of subacute (±)3,4-methylenedioxymethamphetamine administration in rats
    Mairead Geraldine McNamara, John P. Kelly, B.E. Leonard · 1995 · Pharmacology Biochemistry and Behavior
  32. Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices
    John FitzGerald, Julianne J. Reid · 1990 · European Journal of Pharmacology
  33. Neurotoxicity of MDMA: Neurochemical Effects
    CHRISTOPHER J. SCHMID, John H. Kehne · 1990 · Annals of the New York Academy of Sciences
  34. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA
    Lisa H. Gold, Carol B. Hubner, George F. Koob · 1989 · Psychopharmacology
  35. Reserpine attenuates d-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis
    Karen E. Sabol, Lewis S. Seiden · 1998 · Brain Research
  36. Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine
    Christopher J. Schmidt, Christine K. Black, Vicki L. Taylor · 1990 · European Journal of Pharmacology
  37. Studies on the role of dopamine in the degeneration of 5‐HT nerve endings in the brain of Dark Agouti rats following 3,4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy’) administration
    María Isabel Colado, Esther O’Shea, R Granados, B. Moreno Esteban, Alicia Martín, A R Green · 1999 · British Journal of Pharmacology
  38. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats
    K Hewitt · 1994 · Neuropharmacology
  39. MDMA (“Ecstasy”) and panic disorder: Induction by a single dose
    Una D. McCann, George A. Ricaurte · 1992 · Biological Psychiatry
  40. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic mice
    Jean Lud Cadet, Bruce Ladenheim, Hiroshi Hirata, Richard B. Rothman, Syed F. Ali, Elaine J. Carlson, Charles J. Epstein, Timothy H. Moran · 1995 · Synapse
  41. Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites
    Donna M. Stone, Michael Johnson, Glen R. Hanson, James W. Gibb · 1989 · European Journal of Pharmacology Molecular Pharmacology
  42. Hydroxylation of Salicylate and Phenylalanine as Assays for Hydroxyl Radicals: a Cautionary Note Visited for the Third Time
    Barry B. Halliwell, Harparkash Kaur · 1997 · Free Radical Research
  43. Chronic atypical psychosis associated with MDMA ("ecstasy") abuse
    Fabrizio Schifano · 1991 · The Lancet
  44. Ecstasy and neurodegeneration
    A R. Green, Guy M. Goodwin · 1996 · BMJ
  45. Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR
    María Isabel Colado, R Granados, Esther O’Shea, B. Moreno Esteban, A R Green · 1998 · British Journal of Pharmacology
  46. Serum trace elements in animal models and human depression. Part I. Zinc
    Gabriel Nowak, Andrzej Zi ba, Dominika Dudek, Mirosław Krośniak, Maria Szymaczek, Małgorzata Schlegel-Zawadzka · 1999 · Human Psychopharmacology Clinical and Experimental
  47. MDMA (`Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion
    Norberto Aguirre, Santiago Ballaz, Berta Lasheras, Joaquı́n Del Rı́o · 1998 · European Journal of Pharmacology
  48. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced dopamine release and free radical formation in the mouse striatum
    Jorge Camarero, Verónica Sánchez, Esther O’Shea, A. Richard Green, María Isabel Colado · 2002 · Journal of Neurochemistry
  49. 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
    C J Schmidt, Vicki L. Taylor, Gina M. Abbate, Thaddeus R. Nieduzak · 1990 · Journal of Pharmacology and Experimental Therapeutics
  50. Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
    JL Hansen, Evan L. Riddle, Verónica Sandoval, Jeffrey M. Brown, James W. Gibb, Glen R. Hanson, Annette E. Fleckenstein · 2002 · Journal of Pharmacology and Experimental Therapeutics
  51. The effect of 3,4‐methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus
    Mary L. Forsling, John K. Fallon, Darshna Shah, Gary S Tilbrook, David Cowan, Andrew T. Kicman, Andrew J. Hutt · 2002 · British Journal of Pharmacology
  52. Serotonin and thermoregulation: old and new views.
    R.D. Myers · 1981 · PubMed
  53. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives
    Donna M. Stone, Michel Johnson, Glen R. Hanson, James W. Gibb · 1987 · European Journal of Pharmacology
  54. Effect of the R(−) and S(+) isomers of MDA and MDMA on phosphotidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors
    J. Frank Nash, Bryan L. Roth, Jesse D Brodkin, David E. Nichols, Gary A. Gudelsky · 1994 · Neuroscience Letters
  55. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)
    Joseph M. Paris, Kathryn A. Cunningham · 1992 · Brain Research Bulletin
  56. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats
    John H. Kehne, Robert A. Padich, Timothy C. McCloskey, Vicki L. Taylor, C J Schmidt · 1996 · Psychopharmacology
  57. Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst
    Syed Z. Imam, John P. Crow, Glenn D. Newport, Fakhrul Islam, William Slikker, Syed F. Ali · 1999 · Brain Research
  58. Changes in Cardiovascular Responsiveness and Cardiotoxicity Elicited during Binge Administration of Ecstasy
    Lisa A Badon, Alissa R. Hicks, Kevin C. Lord, Brian A Ogden, Suzanne Meleg-Smith, Kurt James Varner · 2002 · Journal of Pharmacology and Experimental Therapeutics
  59. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report
    Liesbeth Reneman, Jan Booij, Jules Lavalaye, Kora M. de Bruin, Johannes B. Reitsma, Boudewijn W. Gunning, Gerard J. den Heeten, Wim van den Brink · 2001 · Psychopharmacology
  60. Effect of 3,4-Methylenedioxymethamphetamine (MDMA) on Hippocampal Dopamine and Serotonin
    Mahalakshmi Shankaran, Gary A. Gudelsky · 1998 · Pharmacology Biochemistry and Behavior
  61. Mazindol Attenuates the 3,4‐Methylenedioxymethamphetamine‐Induced Formation of Hydroxyl Radicals and Long‐Term Depletion of Serotonin in the Striatum
    Mahalakshmi Shankaran, Bryan K. Yamamoto, Gary A. Gudelsky · 1999 · Journal of Neurochemistry
  62. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature
    Márcia C. Carvalho, Félix Dias Carvalho, Fernando Remião, Maria de Lourdes Pereira, Ricardo Pires das Neves, Maria de Lourdes Bastos · 2002 · Archives of Toxicology
  63. Acute 3,4-methylenedioxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat
    Thomas J. Connor, Mairead Geraldine McNamara, David P. Finn, Aoife Currid, Maura O'Malley, Anna Redmond, John P. Kelly, Brian E. Leonard · 1998 · Immunopharmacology
  64. Enzymic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes
    L.Y. Lin, Yoshito Kumagai, Arthur K. Cho · 1992 · Chemical Research in Toxicology
  65. Positron Emission Tomography of 5-HT Transporter Sites in the Baboon Brain with [ 11 C]McN5652
    Zsolt Roland Szabó, Ursula Scheffel, Makiko Suehiro, Robert F. Dannals, Sang Eun Kim, Hayden T. Ravert, George A. Ricaurte, Henry N. Wagner · 1995 · Journal of Cerebral Blood Flow & Metabolism
  66. Evidence for Functional Interactions between 5‐HT1Aand 5‐HT2AReceptors in Rat Thermoregulatory Mechanisms
    Peter Salmi, Sven Ahlénius · 1998 · Pharmacology & Toxicology
  67. Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine
    Richard Ian Dafters, Emily Lynch · 1998 · Psychopharmacology
  68. Information on "Ecstasy"
    GEORGE GREER, Rick J. Strassman · 1985 · American Journal of Psychiatry
  69. Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat
    Robert S. Mansbach, David L. Braff, Mark A. Geyer · 1989 · European Journal of Pharmacology
  70. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
    G.A. Ricaurte · 1988 · JAMA
  71. Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA‐, α1‐ and 5‐HT2A‐receptors
    C. Sebban, B. Tesolin, Jorge Ciprian‐Ollivier, Laurent Perret, Michael Spedding · 2002 · British Journal of Pharmacology
  72. nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice
    Yossef Itzhak, Julio L. Martin, Syed F. Ali · 2000 · Neuroreport
  73. A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation
    Annis O. Mechan, Esther O’Shea, Martin Elliott, Maria Colado, Richard A. Green · 2001 · Psychopharmacology
  74. Vasodilatation and body warming in the rat
    R. T. Grant · 1963 · The Journal of Physiology
  75. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues
    J. Frank Nash, David E. Nichols · 1991 · European Journal of Pharmacology
  76. Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats
    Daniela Braida, Mariaelvina Sala · 2002 · British Journal of Pharmacology
  77. Effects of 7‐Nitroindazole, an NOS Inhibitor on Methamphetamine‐Induced Dopaminergic and Serotonergic Neurotoxicity in Micea
    Syed F. Ali, Yossef Itzhak · 1998 · Annals of the New York Academy of Sciences
  78. Effects of Intracerebroventricular Administration of 5-(Glutathion-S-yl)-α-methyldopamine on Brain Dopamine, Serotonin, and Norepinephrine Concentrations in Male Sprague-Dawley Rats
    Richard Timothy Miller, Serrine S. Lau, Terrence J. Monks · 1996 · Chemical Research in Toxicology
  79. Emotion/cognition-coupling in word recognition memory of depressive patients: an event-related potential study
    D.E. Dietrich, H. M. Emrich, Christiane Waller, Bernardina M. Wieringa, Sönke Johannes, Thomas Frank Münte · 2000 · Psychiatry Research
  80. A study of the mechanism of MDMA (‘Ecstasy’)‐induced neurotoxicity of 5‐HT neurones using chlormethiazole, dizocilpine and other protective compounds
    María Isabel Colado, A.R. Green · 1994 · British Journal of Pharmacology
  81. "Ecstasy" (MDMA)-induced panic
    Patricia M. Whitaker‐Azmitia, T A Aronson · 1989 · American Journal of Psychiatry
  82. Acute Toxicity of 3,4-Methylenedioxymethamphetamine (MDMA) in Sprague–Dawley and Dark Agouti Rats
    A Malpass, Jason M. White, R Julian Irvine, Andrew A. Somogyi, Felix Bochner · 1999 · Pharmacology Biochemistry and Behavior
  83. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward
    Carol B. Hubner, Michael Bird, Stefanie Rassnick, Conan H. Kornetsky · 1988 · Psychopharmacology
  84. The Love Drug: Marching to the Beat of Ecstasy
    Barry Stimmel, Richard S. Cohen · 1998 · Medical Entomology and Zoology
  85. Functional Consequences of Repeated (±)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys
    Michael A. Taffe · 2001 · Neuropsychopharmacology
  86. Clomethiazole (Zendra®) in Acute Ischemic Stroke Basic Pharmacology and Biochemistry and Clinical Efficacy
    A Green · 1998 · Pharmacology & Therapeutics
  87. The Role of Dopaminergic Systems in the Perinatal Sensitivity to 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rats
    Norberto Aguirre, Meritxell Barrionuevo, Berta Lasheras, Joaquı́n Del Rı́o · 1998 · Journal of Pharmacology and Experimental Therapeutics
  88. Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats
    Andreas Mayerhofer, Karl‐Artur Kovar, Werner Schmidt · 2001 · Neuroscience Letters
  89. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats
    Vincent E. V. St. Omer, Syed F. Ali, R.Robert Holson, Helen M. Duhart, Frank M. Scalzo, William Slikker · 1991 · Neurotoxicology and Teratology
  90. Long‐term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine
    Brian T. Callahan, Branden John Cord, George A. Ricaurte · 2001 · Synapse
  91. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    M Johnson, Anita A. Letter, Kalpana Merchant, Glen R. Hanson, James W. Gibb · 1988 · Journal of Pharmacology and Experimental Therapeutics
  92. Microglial response to degeneration of serotonergic axon terminals
    Mary Ann Wilson, Mark E. Molliver · 1994 · Glia
  93. Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine.
    Harry W. Broening, L Bacon, William Slikker · 1994 · Journal of Pharmacology and Experimental Therapeutics
  94. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    C J Schmidt, Gina M. Abbate, Christine K. Black, Vicki L. Taylor · 1990 · Journal of Pharmacology and Experimental Therapeutics
  95. Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging
    Mitchell S. Nobler, J. John Mann, Harold A. Sackeïm · 1999 · Brain Research Reviews
  96. Toxicity of drug abuse — amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use
    Jørg Gustav Mørland · 2000 · Toxicology Letters
  97. Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin
    Gary A. Gudelsky · 1996 · Journal of Neural Transmission
  98. Characterization of the Disruptions of Prepulse Inhibition and Habituation of Startle Induced by α-Ethyltryptamine
    D Martinez · 1997 · Neuropsychopharmacology
  99. 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801
    Michael Dragunow, Barbara J. Logan, Richard Laverty · 1991 · European Journal of Pharmacology Molecular Pharmacology
  100. Enhancement of 3,4‐methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate
    Wendy L. Nixdorf, Kristan B. Burrows, Gary A. Gudelsky, Bryan K. Yamamoto · 2001 · Journal of Neurochemistry
  101. Evidence against an essential role of endogenous brain dopamine in methamphetamine‐induced dopaminergic neurotoxicity
    Jie Yuan, Brian T. Callahan, Una D. McCann, George A. Ricaurte · 2001 · Journal of Neurochemistry
  102. Orally administered MDMA causes a long-term depletion of serotonin in rat brain
    Kevin T. Finnegan, George A. Ricaurte, L.D. Ritchie, Ian Irwin, Stephen J. Peroutka, J. William Langston · 1988 · Brain Research
  103. Subjective ratings of prospective memory deficits in MDMA (‘ecstasy’) users
    Thomas Heffernan, Jonathan Ling, Andrew B Scholey · 2001 · Human Psychopharmacology Clinical and Experimental
  104. Cardiovascular and sympathetic responses and reflex changes elicited by MDMA
    Peggy O'Cain, Sarah B Hletko, Brian A Ogden, Kurt James Varner · 2000 · Physiology & Behavior
  105. Serotonergic Neurotoxicity of 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylendioxymethamphetamine (Ecstasy) Is Potentiated by Inhibition of γ-Glutamyl Transpeptidase
    Fengju Bai, Douglas C. Jones, Serrine S. Lau, Terrence J. Monks · 2001 · Chemical Research in Toxicology
  106. Acute injection of drugs with low addictive potential (Δ9-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine)
    Martina Erdtmann-Vourliotis, Peter Eduard Mayer, Uta Riechert, Volker Höllt · 1999 · Molecular Brain Research
  107. Effects of MDMA on Complex Brain Function in Laboratory Animals
    David Frederick, Merle G. Paule · 1997 · Neuroscience & Biobehavioral Reviews
  108. Reinforcing Subjective Effects of (??) 3,4-Methylenedioxymethamphetamine (???Ecstasy???) May Be Separable from its Neurotoxic Actions
    Una D. McCann, George A. Ricaurte · 1993 · Journal of Clinical Psychopharmacology
  109. Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(methylenedioxy)methamphetamine]
    Zhiyang Zhao, Neal Jr. Castagnoli, George A. Ricaurte, Thomas Steele, Mary Martello · 1992 · Chemical Research in Toxicology
  110. EVIDENCE CONCERNING THE INVOLVEMENT OF 5‐HYDROXYTRYPTAMINE IN THE LOCOMOTOR ACTIVITY PRODUCED BY AMPHETAMINE OR TRANYLCYPROMINE PLUS l ‐DOPA
    A.R. Green, Peter H. Kelly · 1976 · British Journal of Pharmacology
  111. Investigation of the prejunctional α2‐adrenoceptor mediated actions of MDMA in rat atrium and vas deferens
    Aisling Lavelle, Valerie Honner, James R. Docherty · 1999 · British Journal of Pharmacology
  112. Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology
    DAVID L. SIMPSON · 1981 · Archives of Internal Medicine
  113. The action of some amines related to adrenaline
    David Epstein, JAMES A. GUNN, C. J. Virden · 1932 · The Journal of Physiology
  114. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys
    David Frederick, Syed F. Ali, William Slikker, Michael P. Gillam, Richard Read Allen, Merle G. Paule · 1995 · Neurotoxicology and Teratology
  115. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
    Liesbeth Reneman, Charles B.L.M. Majoie, Herman Flick, Gerard J. den Heeten · 2002 · PubMed Central
  116. Ear-Clicking Tinnitus Responding to Carbamazepine
    M.K. Mardini · 1987 · New England Journal of Medicine
  117. Responses of the Nervous System to Low Frequency Stimulation and EEG Rhythms: Clinical Implications
    Norman M. Salansky, Alexander I. Fedotchev, А. Т. Бондарь · 1998 · Neuroscience & Biobehavioral Reviews
  118. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors
    Scheffel, Ursula, Lever, J.R., Stathis, M., Ricaurte, G.A. · 1992 · Neuropharmacology
  119. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men
    Herbert Y. Meltzer, Michael H. J. Maes · 1995 · Psychiatry Research
  120. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the wistar rat
    Eamond D. O'Loinsigh, Gerard M. Boland, John P. Kelly, Kathy M. O’Boyle · 2001 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  121. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
    Ram Gollamudi, Ali Sf, George W. Lipe, Glenn D. Newport, Peggy J. Webb, M. D. Gutiérrez López, Julian E.A. Leakey, Malak G. Kolta, William Slikker · 1989 · PubMed
  122. Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')
    C. Brown · 1987 · JAMA
  123. Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats
    Norberto Aguirre, JoséL. Galbete, Berta Lasheras, Joaquı́n Del Rı́o · 1995 · European Journal of Pharmacology
  124. Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity
    Jie Yuan, Branden John Cord, Una D. McCann, Brian T. Callahan, George A. Ricaurte · 2002 · Journal of Neurochemistry
  125. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Marcus Rattray · 1991 · PubMed
  126. Stereoselective pharmacokinetics of 3,4‐methylenedioxymethamphetamine in the rat
    Robert L. Fitzgerald, Robert V. Blanke, Alphonse Poklis · 1990 · Chirality
  127. MDMA (‘ecstasy’) exhibits an anxiogenic-like activity in social encounters between male mice
    E. Maldonado, José Francisco Navarro · 2001 · Pharmacological Research
  128. The effect of IV l-tryptophan on prolactin, growth hormone, and mood in healthy subjects
    Dennis S. Charney, George R. Heninger, John F. Reinhard, David E. Sternberg, Karen M. Hafstead · 1982 · Psychopharmacology
  129. Chronic paranoid psychosis after misuse of MDMA.
    ADAM R. WINSTOCK · 1991 · BMJ
  130. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
    Yoshito Kumagai, L Y Lin, Akira Hiratsuka, Shizuo Narimatsu, Tokuji Suzuki, Hideyuki Yamada, Kazuta Oguri, Hidetoshi Yoshimura, Arthur K. Cho · 1994 · Molecular Pharmacology
  131. On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA
    A. Richard Green, Iain S. McGregor · 2002 · Psychopharmacology
  132. Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine (“ecstasy”): is metabolism a contributory factor?
    Mary L. Forsling, John K. Fallon, Andrew T. Kicman, Andrew J. Hutt, David Cowan, John Aaron Henry · 2001 · Journal of Pharmacy and Pharmacology
  133. Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the dark agouti rat
    Linda Quate, Douglas E. McBean, Isobel M. Ritchie, Henry J. Olverman, Paul A. T. Kelly · 2004 · Psychopharmacology
  134. Functional consequences of perinatal exposure to3,4‐methylenedioxymethamphetamine in rat brain
    Paul A T Kelly, Isobel M. Ritchie, Linda Quate, Douglas E. McBean, Henry J. Olverman · 2002 · British Journal of Pharmacology
  135. Characterisation of Human 5‐Hydroxytryptamine2A and 5‐Hydroxytryptamine2C Receptors Expressed in the Human Neuroblastoma Cell Line SH‐SY5Y: Comparative Stimulation by Hallucinogenic Drugs
    R. A. Newton, SUE L. PHIPPS, Thomas P. Flanigan, Nigel R. Newberry, James E. Carey, C S Kumar, B. McDonald, C. Chen, J. Martin Elliott · 1996 · Journal of Neurochemistry
  136. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit
    Taleen Hanania, Gilbert R. Hillman, Kenneth M. Johnson · 1999 · Synapse
  137. Metabolism of 5-(Glutathion-S-yl)-.alpha.-methyldopamine following Intracerebroventricular Administration to Male Sprague-Dawley Rats
    Richard Timothy Miller, Serrine S. Lau, Terrence J. Monks · 1995 · Chemical Research in Toxicology
  138. Vascular actions of MDMA involve α1 and α2‐adrenoceptors in the anaesthetized rat
    John McDaid, James R. Docherty · 2001 · British Journal of Pharmacology
  139. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat
    Gerard J. Marek, Georgetta Vosmer, Lewis S. Seiden · 1990 · Brain Research
  140. Sympathomimetic Actions of Methylenedioxymethamphetamine in Rat and Rabbit Isolated Cardiovascular Tissues
    John FitzGerald, Julianne J. Reid · 1994 · Journal of Pharmacy and Pharmacology
  141. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    John H. Kehne, Timothy C. McCloskey, Vicki L. Taylor, Christine K. Black, Gina M. Fadayel, C J Schmidt · 1992 · Journal of Pharmacology and Experimental Therapeutics
  142. Involvement of free radicals in MDMA-induced neurotoxicity in mice.
    Jean Lud Cadet, Nathalie Thiriet, Subramaniam Jayanthi · 2001 · PubMed
  143. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices
    John FitzGerald, Julianne J. Reid · 1993 · Naunyn-Schmiedeberg s Archives of Pharmacology
  144. Chronic treatment with supraphysiological levels of corticosterone enhances d-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse
    Elizabeth Anne Johnson, James Patrick O'Callaghan, Diane Bemis Miller · 2002 · Brain Research
  145. Methysergide potentiates the hyperactivity produced by MDMA in rats
    Lisa H. Gold, George F. Koob · 1988 · Pharmacology Biochemistry and Behavior
  146. GEPTAKHOR
    VALENTINA, VIKTOR TEIDER · 1996 · Experiment
  147. P-chloroamphetamine induces C-fos in rat brain: A study of serotonin2A/2C receptor function
    Jennifer M. Moorman, R.A. Leslie · 1996 · Neuroscience
  148. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys
    Mark S. Kleven, William L. Woolverton, Lewis S. Seiden · 1989 · Brain Research
  149. Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats
    V Sanchez · 2003 · Neuropharmacology
  150. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine
    Claude Rouillard, Sylvie Bovetto, Julie Gervais, Denis Richard · 1996 · Molecular Brain Research
  151. Aplastic anaemia following exposure to 3,4‐methylenedioxymethamphetamine (‘Ecstasy’)
    Judith C. W. Marsh, Z Abboudi, Frances M. Gibson, John Scopes, Stephen Daly, D. F. O'Shaunnessy, A. S. J. Baughan, E. C. Gordon‐Smith · 1994 · British Journal of Haematology
  152. Methamphetamine toxicity in mice is potentiated by exposure to loud music
    A. Jennifer Morton, Miriam Ann Hickey, Laura C. Dean · 2001 · Neuroreport
  153. Role of brain nitric oxide in (±)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats
    Yiwen Zheng, Richard Laverty · 1998 · Brain Research
  154. Evidence thatm-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors
    Pascale Mazzola‐Pomietto, Charanjit S. Aulakh, Kinga Woźniak, Dennis L. Murphy · 1996 · Psychopharmacology
  155. An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA
    Erin M. Falk, Valerie J. Cook, David E. Nichols, Jon E. Sprague · 2002 · Pharmacology Biochemistry and Behavior
  156. Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: Implications for pharmacological studies
    Christopher J. Gordon, Lela Fogelson · 1994 · Physiology & Behavior
  157. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats
    Masayuki Hiramatsu, Toshitaka NABESHIMA, Tsutomu Kameyama, Y. Maeda, Arthur K. Cho · 1989 · Pharmacology Biochemistry and Behavior
  158. Ion trap tandem mass spectrometric evidence for the metabolism of 3,4-(methylenedioxy)methamphetamine to the potent neurotoxins 2,4,5-trihydroxymethamphetamine and 2,4,5-trihydroxyamphetamine
    Hyun Kyoon Lim, R. L. Foltz · 1991 · Chemical Research in Toxicology
  159. MDMA and Learning
    Tom Byrne, Lisa E. Baker, Alan D. Poling · 2000 · Pharmacology Biochemistry and Behavior
  160. In vivo evidence against clomethiazole being neuroprotective against MDMA (‘ecstasy’)-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism
    María Isabel Colado, Esther O’Shea, B. Moreno Esteban, R Granados, A.R Green · 1999 · Neuropharmacology
  161. A study of the mechanism of insulin
    J. Secker · 1925 · The Journal of Physiology
  162. d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity
    Elizabeth Anne Johnson, Anna A. Shvedova, Elena R. Kisin, James Patrick O'Callaghan, Choudari Kommineni, Diane Bemis Miller · 2002 · Brain Research
  163. In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: Identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques
    Hyun Kyoon Lim, R. L. Foltz · 1991 · Journal of Mass Spectrometry
  164. Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity
    Brian T. Callahan, George A. Ricaurte · 1998 · Neuroreport
  165. 3,4-Methylenedioxymethamphetamine Produces Glycogenolysis and Increases the Extracellular Concentration of Glucose in the Rat Brain
    Altaf S. Darvesh, Mahalakshmi Shankaran, Gary A. Gudelsky · 2002 · Journal of Pharmacology and Experimental Therapeutics
  166. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats
    Andrew Harkin, Thomas J. Connor, Jane B. Mulrooney, John P. Kelly, Brian E. Leonard · 2001 · Life Sciences
  167. Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration
    M. Isabel Colado, B. Moreno Esteban, Esther O’Shea, R Granados, A. R. Green · 1999 · Psychopharmacology
  168. Methylenedioxyamphetamine
    Dennis L. Simpson · 1981 · Archives of Internal Medicine
  169. Acute Effects of Dexfenfluramine (d‐FEN) and Methylenedioxymethamphetamine (MDMA) before and after Short‐Course, High‐Dose Treatment
    David Frederick, Syed F. Ali, Michael P. Gillam, Jeff Gossett, William Slikker, Merle G. Paule · 1998 · Annals of the New York Academy of Sciences
  170. Restraint as a stressor in mice:
    Elizabeth A. Johnson, Dan S. Sharp, Diane Bemis Miller · 2000 · Brain Research
  171. Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions
    Neil E. Rowland, Audrey N. Kalehua, B.-H. Li, Susan L. Semple‐Rowland, Wolfgang J. Streit · 1993 · Brain Research
  172. Validity of [123I]β‐CIT SPECT in detecting MDMA‐induced serotonergic neurotoxicity
    Liesbeth Reneman, Jan Booij, Jan B. A. Habraken, Kora M. de Bruin, George Hatzidimitriou, Gerard J. den Heeten, George A. Ricaurte · 2002 · Synapse
  173. Anorectic activities of serotonin uptake inhibitors: Correlation with their potencies at inhibiting serotonin uptake and 3H-mazindol binding
    Itzchak Angel, Marie-Anne Taranger, Yves Claustre, B. Scatton, Salomón Z. Langer · 1988 · Life Sciences
  174. ‘Ecstasy’ Ingestion: A Case Report of Severe Complications
    P.J. Barrett, George Taylor · 1993 · Journal of the Royal Society of Medicine
  175. Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat
    Gersham Wilkerson, Edythe D. London · 1989 · Neuropharmacology
  176. Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man
    Eleni Palazidou, J. Stephenson, J. Butler, Patsy Coskeran, S. Chambers, Anthony McGregor · 1995 · Psychopharmacology
  177. MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro
    Stephany M. Biello, Richard Ian Dafters · 2001 · Brain Research
  178. Caveat Emptor Editors Beware
    F.X. Vollenweider · 2001 · Neuropsychopharmacology
  179. Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity
    Shunzi Che, Michel Johnson, Glen R. Hanson, James W. Gibb · 1995 · European Journal of Pharmacology Environmental Toxicology and Pharmacology
  180. Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP
    Larry R. Steranka, Alexander W. Rhind · 1987 · European Journal of Pharmacology
  181. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine
    Tanya L. Wallace, Gary A. Gudelsky, Charles V. Vorhees · 2000 · Psychopharmacology
  182. Long-term partial 5-HT depletion: interference of anxiety and impulsivity?
    Jaanus Harro · 2002 · Psychopharmacology
  183. Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice
    Yumi Sugimoto, Minako Ohkura, Kiyo Inoue, Jun Yamada · 2001 · European Journal of Pharmacology
  184. Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): An experimental study
    Salil K. Bhattacharya, Arunabh Bhattacharya, Shibnath Ghosal · 1998 · Biogenic Amines
  185. Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation
    Hui Qiang Lin, David M. Jackson, Dale M. Atrens, MacDonald J. Christie, Iain S. McGregor · 1997 · Brain Research
  186. Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration
    Peter John Winsauer, Una D. McCann, J. Yuan, Marcus Sherode Delatte, Michael Stevenson, George A. Ricaurte, Joseph M. Moerschbaecher · 2002 · Psychopharmacology
  187. The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine
    Tracey K. Murray, Jodi L. Williams, Aditya Misra, M. Isabel Colado, A.R Green · 1996 · Neuropharmacology
  188. Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men
    Herbert Y. Meltzer, Michael H. J. Maes · 1995 · Biological Psychiatry
  189. Naltrindole, a δ-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation
    Larry D. Reid, Christopher L. Hubbell, Jeannie Tsai, Michael D. Fishkin, Christopher A. Amendola · 1996 · Pharmacology Biochemistry and Behavior
  190. An Appraisal of the Pharmacological and Toxicological Effects of a Single Oral Administration of 3,4‐Methylenedioxymethamphetamine (MDMA) in the Rat
    Ivone de Souza, John P. Kelly, Andrew Harkin, Brian E. Leonard · 1997 · Pharmacology & Toxicology
  191. Psychiatric symptoms in cannabis users
    Philip K. McGuire, Peter Brian Jones, Robin M. Murray · 1993 · The British Journal of Psychiatry
  192. Effects of Salicylate on 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Neurotoxicity in Rats
    Shuyuan Yeh · 1997 · Pharmacology Biochemistry and Behavior
  193. HYPERTHERMIA IN d-AMPHETAMINE TOXICITY IN AGGREGATED MICE OF DIFFERENT STRAINS
    ARTHUR L. CRAIG, Harvey J. Kupferberg · 1972 · Journal of Pharmacology and Experimental Therapeutics
  194. MDMA Effects in Brain: Pharmacologic Profile and Evidence of Neurotoxicity from Neurochemical and Autoradiographic Studies
    George Battaglia, Robert C. Zaczek, Errol B. De Souza · 1990 · Topics in the neurosciences
  195. Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality.
    David M. Bronstein, Jau‐Shyong Hong · 1995 · Journal of Pharmacology and Experimental Therapeutics
  196. A Growing Industry and Menace: Makeshift Laboratory's Designer Drugs
    Terra D. Ziporyn · 1986 · JAMA
  197. Effect of the Repeated Administration of (±)-3,4-Methylenedioxymethamphetamine on the Behavioral Response of Rats to the 5-HT1A Receptor Agonist (±)-8-Hydroxy-(di-n-Propylamino)Tetralin
    Martin I. Granoff, Charles R. Ashby · 2001 · Neuropsychobiology
  198. Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery
    W Al-Sahli, Husaimah Ahmad, Farhad Kheradmand, Claire Connolly, James R. Docherty · 2001 · European Journal of Pharmacology
  199. Effects of "Ecstasy" Blocked by Serotonin Reuptake Inhibitors
    Dan Joseph Stein, Jeffrey Rink · 1999 · The Journal of Clinical Psychiatry
  200. The Love Drug
    Andrew Weil · 1976 · Journal of Psychedelic Drugs